Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 2013 Aug 1;123(8):3634. doi: 10.1172/JCI71197

Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells

Cristian Bellodi, Maria Rosa Lidonnici, Ashley Hamilton, G Vignir Helgason, Angela Rachele Soliera, Mattia Ronchetti, Sara Galavotti, Kenneth W Young, Tommaso Selmi, Rinat Yacobi, Richard A Van Etten, Nick Donato, Ann Hunter, David Dinsdale, Elena Tirrò, Paolo Vigneri, Pierluigi Nicotera, Martin J Dyer, Tessa Holyoake, Paolo Salomoni, Bruno Calabretta
PMCID: PMC3972029

Original citation: J. Clin. Invest. 2009;119(5):1109–1123. doi:10.1172/JCI35660.

Citation for this corrigendum: J. Clin. Invest. 2013;123(8):3634. doi:10.1172/JCI71197.

Due to an oversight during figure preparation, an incorrect blot was inserted in Figure 1D. The correct figure part appears below.

Figure 1.

Figure 1

Open in a new tab

The authors regret the error.

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES